Skip to main content

Kenya's Strides Against HIV and Viral Hepatitis Among Drug Users

 

Austria, Vienna - 15th March 2024 - 

In Kenya, a groundbreaking initiative is tackling the pervasive threat of HIV and viral hepatitis, particularly among people who inject drugs (PWID). With over 50% of cases prevented, this program draws upon global best practices, reaching an impressive 80% of Kenya's nearly 27,000 PWID population.

Mr. Harry Kimtai, the Principal Secretary of the State Department for Medical Services, underscored Kenya's multifaceted strategy during the 67th Session of the Commission on Narcotic Drugs in Vienna, Austria. This approach emphasizes not only medical interventions but also community involvement and empowerment. By engaging PWID directly in intervention design and execution, trust is fostered, and culturally appropriate strategies are ensured.

Central to the program's success is its peer education component. Former or current PWID are equipped with vital knowledge on HIV and viral hepatitis transmission, harm reduction techniques, and access to healthcare services. This peer-to-peer approach effectively reaches marginalized populations, encouraging their engagement with healthcare.

Furthermore, the program prioritizes harm reduction strategies, including needle and syringe exchange and opioid substitution therapy. These initiatives not only mitigate the transmission of HIV and hepatitis but also address substance addiction, offering PWID a path to rehabilitation and recovery.

Kenya's achievements are bolstered by its integration of best practices from around the globe, tailored to local contexts. Continued investment and collaboration with international donors such as PEPFAR and the Global Fund, led by UNODC, ensure sustainable progress. The Kenya Kwanza administration's commitment to addressing underlying social determinants, including poverty and stigma, further supports effective prevention and treatment efforts.

Dr. Ruth Laibon, Chief Executive Officer of the National Syndemic Diseases Control Council, lauds Kenya's innovative and community-driven approach as a beacon of success. She emphasizes the nation's dedication to expanding these efforts to ultimately eliminate HIV and viral hepatitis.